These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26975509)

  • 1. HCN Channels Modulators: The Need for Selectivity.
    Novella Romanelli M; Sartiani L; Masi A; Mannaioni G; Manetti D; Mugelli A; Cerbai E
    Curr Top Med Chem; 2016; 16(16):1764-91. PubMed ID: 26975509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCN Channel as Therapeutic Targets for Heart Failure and Pain.
    Cao Y; Pang J; Zhou P
    Curr Top Med Chem; 2016; 16(16):1855-61. PubMed ID: 26667117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a series of novel HCN channel inhibitors.
    Chen SJ; Xu Y; Liang YM; Cao Y; Lv JY; Pang JX; Zhou PZ
    Acta Pharmacol Sin; 2019 Jun; 40(6):746-754. PubMed ID: 30315249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.
    He JT; Li XY; Zhao X; Liu X
    Rev Neurosci; 2019 Jul; 30(6):639-649. PubMed ID: 30768426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
    Sartiani L; Romanelli MN; Mugelli A; Cerbai E
    Curr Drug Targets; 2015; 16(8):868-76. PubMed ID: 26028050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCN Channels: New Therapeutic Targets for Pain Treatment.
    Ramírez D; Zúñiga R; Concha G; Zúñiga L
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30134541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HCN channel as a pharmacological target: Why, where, and how to block it.
    Balducci V; Credi C; Sacconi L; Romanelli MN; Sartiani L; Cerbai E
    Prog Biophys Mol Biol; 2021 Nov; 166():173-181. PubMed ID: 34303730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.
    Weerasinghe D; Menon P; Vucic S
    J Neurophysiol; 2017 Dec; 118(6):3044-3050. PubMed ID: 28904107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
    Wang J; Yang YM; Li Y; Zhu J; Lian H; Shao XH; Zhang H; Fu YC; Zhang LF
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):242-252. PubMed ID: 30302853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability.
    Spinelli V; Sartiani L; Mugelli A; Romanelli MN; Cerbai E
    Can J Physiol Pharmacol; 2018 Oct; 96(10):977-984. PubMed ID: 29969572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: HCN Channels in the Heart.
    Depuydt AS; Peigneur S; Tytgat J
    Curr Cardiol Rev; 2022; 18(4):e040222200836. PubMed ID: 35125083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels.
    Sartiani L; Mannaioni G; Masi A; Novella Romanelli M; Cerbai E
    Pharmacol Rev; 2017 Oct; 69(4):354-395. PubMed ID: 28878030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues.
    Romanelli MN; Del Lungo M; Guandalini L; Zobeiri M; Gyökeres A; Árpádffy-Lovas T; Koncz I; Sartiani L; Bartolucci G; Dei S; Manetti D; Teodori E; Budde T; Cerbai E
    ACS Med Chem Lett; 2019 Apr; 10(4):584-589. PubMed ID: 30996800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and neuronal HCN channelopathies.
    Rivolta I; Binda A; Masi A; DiFrancesco JC
    Pflugers Arch; 2020 Jul; 472(7):931-951. PubMed ID: 32424620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.
    Santoro B; Shah MM
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():109-131. PubMed ID: 31914897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of ivabradine block of the open pore of HCN4.
    Saponaro A; Krumbach JH; Chaves-Sanjuan A; Sharifzadeh AS; Porro A; Castelli R; Hamacher K; Bolognesi M; DiFrancesco D; Clarke OB; Thiel G; Moroni A
    Proc Natl Acad Sci U S A; 2024 Jul; 121(27):e2402259121. PubMed ID: 38917012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCN channels and heart rate.
    Scicchitano P; Carbonara S; Ricci G; Mandurino C; Locorotondo M; Bulzis G; Gesualdo M; Zito A; Carbonara R; Dentamaro I; Riccioni G; Ciccone MM
    Molecules; 2012 Apr; 17(4):4225-35. PubMed ID: 22481543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing broad-spectrum and isoform-preferring HCN channel blockers for anticonvulsant properties in mice.
    Kharouf Q; Pinares-Garcia P; Romanelli MN; Reid CA
    Epilepsy Res; 2020 Dec; 168():106484. PubMed ID: 33099130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Function in Thalamocortical Neurons Prevents Genetically Determined and Pharmacologically Induced Absence Seizures.
    David F; Çarçak N; Furdan S; Onat F; Gould T; Mészáros Á; Di Giovanni G; Hernández VM; Chan CS; Lőrincz ML; Crunelli V
    J Neurosci; 2018 Jul; 38(30):6615-6627. PubMed ID: 29925625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels by β-blocker carvedilol.
    Cao Y; Chen S; Liang Y; Wu T; Pang J; Liu S; Zhou P
    Br J Pharmacol; 2018 Oct; 175(20):3963-3975. PubMed ID: 30098004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.